$USAC

United States Antimony Corporation Q2 2026 Earnings Call Summary

United States Antimony Corp. reported Q2 2026 revenue down 25% year over year, driven mainly by a 52% fall in realized antimony prices. The company is building $21.6M inventory for its sole-source DLA contract and raised zeolite segment revenue 110%. Full-year 2026 revenue guidance was cut to $60-$75M due to lower pricing; it has $62.2M cash plus a $43.2M Larvotto equity stake.

Original reporting
Published Aug 13, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
United States Antimony Corporation Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$USACNeutralMed
01

Why it matters

Traders should treat the guidance reduction as a direct function of realized antimony prices, while monitoring DLA inspection and logistics milestones that determine when high-margin deliveries flow into reported results.

02

Market read

The key tradable update is the lowered 2026 revenue guidance ($60-$75m) explicitly attributed to antimony pricing, alongside stated progress on DLA deliveries and expected margin expansion tied to inspection-driven revenue recognition.

03

What to watch

Inventory build ($21.6m) and the $275m pending DOE/DOD grants could materially affect working capital and funding optionality, but the article does not quantify probability or timing of grant outcomes.

Relevance 7/10Novelty 6/10Timing: post-market earnings call summary, guidance and DLA timing updates for 2026

Background

USAC’s Q2 2026 earnings call focuses on antimony price weakness, inventory strategy, and progress toward sole-source DLA deliveries plus domestic mining ramp.

Company-level read

Ticker impact

$USACNeutralMedium confidence
Context

United States Antimony Corporation lowered full-year 2026 revenue guidance to $60-$75 million, citing realized antimony price weakness and DLA delivery timing.

Expected impact

Near-term volatility likely, with downside risk if antimony prices stay below management’s $10/lb profitability framework; upside if DLA deliveries are recognized sooner than inspection delays.

Evidence & confidence

The article provides concrete guidance range, states the revision is solely antimony-price driven, and links future margin expansion to official recognition of high-margin DLA deliveries after inspections.

Market effects

Highlights how defense procurement and inspection delays can shift revenue recognition for strategic materials producers, increasing earnings timing risk.

Montana and Idaho project timelines remain a key swing factor for USAC’s domestic supply ramp.

Reinforces sensitivity of antimony producers to global pricing and potential supply-chain manipulation concerns tied to China.

Counterpoint

If antimony prices stabilize near management’s $10/lb assumption, the guidance cut may prove temporary, and DLA delivery recognition could re-rate margins faster than expected.

Key entities

  • United States Antimony Corporation

    Subject of the earnings call summary, providing 2026 guidance, DLA delivery expectations, and project/margin outlook.

  • Defense Logistics Agency (DLA)

    Sole-source contract referenced for inventory build and delivery order timing that affects revenue recognition.

  • Larvotto Resources

    USAC holds a $43.2m strategic equity investment and discusses potential liquidity treatment after takeover attempts.

  • MSHA

    Regulatory body whose approval timing at Stibnite Hill affected resumption of mining and operating safeguards.

  • DOE and DOD

    Pending $275m in grant applications that may shift toward equity-based funding structures.

Related articles

$USACMed

USA Compression Partners Q2 Earnings Call Highlights

USA Compression Partners (NYSE:USAC) reported Q2 metrics including 4.95 million total fleet horsepower, 92% utilization, and average revenue per revenue-generating horsepower per month of $22.84. Adjusted gross margin was 63.5% and leverage was 3.72x. The firm reaffirmed 2026 outlook for adjusted EBITDA $770m-$800m and distributable cash flow $480m-$510m, plus capex guidance.

$USACMed

USA Compression Partners, LP (USAC): Results of Operations and Financial Condition

USA Compression Partners, LP (USAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 usacq22026ex991.htm EX-99.1 Document Exhibit 99.1 News Release USA Compression Partners, LP 8115 Preston Road, Suite 700 Dallas, Texas 75225 usacompression.com USA Compression Partners Reports Second-Quarter 2026 Results DALLAS, Texas, August 4, 2026 — USA Compression P

$GSKMed

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

GSK plc reported Q2 results on July 28. Total turnover was £8.4bn, up 5% CER. Core operating profit rose 7% CER to £2.80bn and Core EPS increased 9% CER to 50.5p, driven by Specialty Medicines and Vaccines. Total operating profit fell 75% CER due to a £1.3bn non-cash impairment after discontinuing camlipixant. GSK also outlined a 2026 Phase III acceleration plan and a £1.9bn annual cost-savings restructuring program.

$BFRIMedAI 8/10

Biofrontera Posts Strong Q2 2026 Results On 33% Revenue Growth

Biofrontera (BFRI) reported Q2 2026 net product revenue of $12.0M, up 32.9% from $9.0M, with gross margin rising to 80% from 71%. Net loss narrowed to $0.6M from $5.3M. For six months, revenue was $22.1M (+25.4%) and gross margin 80%. A PDUFA decision for Ameluz is expected Sept. 28, 2026.

$UPWKMedAI 8/10

Why Upwork (UPWK) Stock Is Nosediving

Upwork (UPWK) shares fell about 10% after the company reported Q2 results that beat estimates but issued weaker full-year revenue and EPS guidance. Analysts at Scotiabank and RBC cut price targets to $10 and $9 from $15 and $20, respectively, while keeping Sector Perform ratings. The stock is down sharply year to date amid AI and labor-market concerns.